Home > Newsletters > FDAnews Drug Daily Bulletin > CMO Guidance to Discuss Quality Accord Expectations: FDA Official
FDAnews Drug Daily Bulletin
Oct. 4, 2012 | Vol. 9 No. 195
CMO Guidance to Discuss Quality Accord Expectations: FDA Official
The FDA will issue guidance detailing what information drugmakers should share with contract manufacturing organizations (CMO) hired to work on their products, FDA officials say. “Clarification is greatly needed because each agreement is crafted differently and we have to step in when there’s a quality problem,” Kathleen Culver, field investigator and drug preapproval manager with the agency’s Cincinnati District office, said. Culver spoke Sept. 24 at the FDA/Xavier Global Outsourcing Conference.
Washington Drug Letter
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.